Cover stories

Biomedical and life sciences – an opportunity for brokers

The UK biomedical and life sciences sector generates £52bn annually from businesses across the pharmaceutical, biotechnology, medical device, dietary supplement, medical food, laboratory instruments and equipment industries.

These markets have historical strong growth and forecast rates are 8-10% per annum. The sector is SME driven and regionally diverse; it’s not just focussed around London and the South East, with activity in Scotland, South Wales and North West England, especially Liverpool and Manchester.


Read the full report to find out more about the sector and the wide range of opportunities it affords the broking community.